Combining allogeneic immunotherapy with an mTOR inhibitor for advanced renal cell carcinoma.
Tykodi
S S
SS
Voong
L N
LN
Warren
E H
EH
D002292:Carcinoma, Renal Cell / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007680:Kidney Neoplasms / Q000628:therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D014184:Transplantation, Homologous
D047428:Protein Kinase Inhibitors; D058570:TOR Serine-Threonine Kinases